AI in pediatric brain cancer is paving the way for groundbreaking advancements in diagnosing and predicting relapse risk for young patients suffering from conditions like pediatric gliomas.A recent study revealed that an AI tool could outperform traditional methods by analyzing longitudinal brain scans, providing a more accurate assessment of potential recurrence.